MedTech market research in the UK: a step-by-step guide

How UK medtech companies can size demand and map NHS buyers before commercial launch.

Book a free consultation

MedTech market research in the UK is harder than consumer research, because the person who uses your device, the person who pays and the person who approves the purchase are often three different people in three different parts of the NHS.

This guide sets out a step-by-step method for UK medical device and diagnostics companies, from sizing demand to testing your value case with clinicians and procurement teams.

Step 1: define the clinical and commercial question

Start with a precise question. Examples: how many patients per year could use this device in England, which care setting adopts first, or what evidence will procurement want?

Write the intended use and target pathway in a single paragraph. Every later step depends on it.

Step 2: size the market from the bottom up

Begin with the patient population for the condition, using published national and NHS data sources. Narrow it to the group your device is designed for, then to those treated in settings you can reach.

  • Total market: all patients with the relevant condition.
  • Serviceable market: those eligible for your device in the settings you target.
  • Obtainable market: the share you can win given evidence, price and sales capacity.

Say 100,000 patients are eligible and a device is used once per patient at an illustrative £150. That gives a £15 million ceiling to compare against realistic adoption rates, not a forecast.

Step 3: map the buying process

NHS purchasing is layered. A clinician may champion a device, but approval often involves a clinical lead, a finance director, a procurement team and sometimes an integrated care board.

Interview people in each role. Ask who raises the need, who evaluates, who signs off, what budget it draws from and how long the cycle takes in an acute trust compared with primary care or a private provider.

Step 4: interview clinicians and buyers

Plan 20 to 30 interviews across at least three groups: clinicians who would use the device, managers who control budgets and procurement specialists. Include London, Manchester, Birmingham and Edinburgh to capture regional differences, including devolved nations.

What to ask

  • How is the condition managed today, and what frustrates you about it?
  • What evidence would you need to change practice?
  • What would block adoption, such as training, integration or cost?

Step 5: test the value proposition

Show a short value summary to 60 to 100 target buyers and measure clarity, credibility and likelihood to trial. Compare versions that stress clinical outcomes, time saved or cost reduction.

Hospitals under budget pressure often respond to cost avoidance and capacity gains. Clinicians usually respond to outcomes and ease of use. Your message may need to be different for each.

StakeholderLikely priorityResearch method
ClinicianOutcomes, workflowDepth interview
Finance leadCost, budget impactDepth interview, price test
ProcurementCompliance, contract fitInterview, document review

Step 6: keep within regulatory boundaries

Research is not promotion, but conversations about unapproved products need care. Devices must meet UK conformity requirements, regulated by the MHRA, so make clear in research materials what stage the product is at and avoid claims you cannot evidence.

Collect clinician data under UK GDPR with clear consent, and never use patient data without a lawful basis and appropriate approvals.

Step 7: decide and plan

Close with a go-to-market memo covering your first target setting, the buying roles, the evidence gap and a realistic adoption forecast. For help scoping a study, see our services page.

Mistakes that slow medtech launches

  • Talking only to clinical champions and ignoring finance and procurement.
  • Assuming an NHS pathway in England applies in Scotland, Wales or Northern Ireland.
  • Sizing the market from the whole patient population instead of eligible patients.
  • Underestimating training, integration and data governance effort for the buyer.

Private providers and the NHS

Private hospital groups and independent clinics often decide faster than NHS trusts, and they weigh return on investment more directly. Many medtech firms start there to build usage data and references before approaching larger public buyers.

Research both. Compare how each group learns about products, who influences them and which evidence they trust.

Using the findings to shape evidence plans

Interviews usually reveal an evidence gap: the data buyers want and the data you have. Turn that gap into a plan covering clinical studies, health economic modelling and real-world pilots.

Prioritise the evidence that opens up your first target setting. A single well-run pilot in one trust can be worth more than a broad but thin set of claims.

A short checklist before you start

  • Write the intended use and target pathway in one paragraph.
  • List every role in the buying chain, from champion to procurement.
  • Prepare a neutral description of the device that avoids unsupported claims.
  • Agree how you will thank NHS participants without breaching local rules on gifts.

Offer participants a summary of findings. Clinicians are more willing to talk again when they see that their time produced something useful.

Frequently asked questions

How many interviews does a medtech study need?

Twenty to thirty across clinicians, managers and procurement is typical. Add more if you target several care settings or devolved nations.

Can we interview NHS staff?

Yes, though availability is limited and some trusts have rules on outside research. Offer flexible short calls and check whether any local approvals apply.

Is desk research enough?

No. Published data shows the size of the patient population but not how buyers decide, which only interviews will reveal.

Want help with this? See our Intelligence & research service, or how we work in healthcare branding.

Explore Intelligence & researchHealthcare branding

Let's build your brand.

Book a free consultation